Ultrasound image-guided radiation therapy (IGRT) developer Resonant Medical will showcase the next generation of its Clarity IGRT system at this week's European Society for Therapeutic Radiology and Oncology (ESTRO) annual meeting in Maastricht, Netherlands.
The new version supports adaptive radiation therapy for soft-tissue cancers, alerting physicians of changes in a target structure's precise location, shape, and size, according to the Montreal-based firm. Users can then utilize the information to adapt the patient's treatment plan.
The Maastro Clinic in Maastricht has begun offering Clarity for prostate and breast cancer treatments, Resonant said.
Copyright © 2009 AuntMinnie.com